Skip to main content
SpringerLink
Log in

Postmortem-derived iPSC models in substance use disorders research

  • Hot Topics
  • Published:
Neuropsychopharmacology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Using postmortem-derived iPSC lines to model drug exposure.

References

  1. Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, et al. Using iPSC‐derived human DA neurons from opioid‐dependent subjects to study dopamine dynamics. Brain Behav. 2016;6:491.

    Article  Google Scholar 

  2. Halikere A, Popova D, Scarnati MS, Hamod A, Swerdel MR, Moore JC, et al. Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons. Mol Psychiatry. 2019;25:1406–19.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mendez EF, Grimm SL, Stertz L, Gorski D, Movva SV, Najera K, et al. A human stem cell-derived neuronal model of morphine exposure reflects brain dysregulation in opioid use disorder: Transcriptomic and epigenetic characterization of postmortem-derived iPSC neurons. Front Psychiatry. 2023;14:1070556.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ho, MF, Zhang, C, Moon, I, Zhu, X, Coombes, BJ, Biernacka, J, et al. Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder. Mol Psychiatry. 2022. https://doi.org/10.1038/s41380-022-01837-8. Epub ahead of print.

  5. Zuk P, Stertz L, Walss-Bass C, Lázaro-Muñoz G. Research comparing iPSC-derived neural organoids to ex vivo brain tissue of postmortem donors: identity after life? AJOB Neurosci. 2022;13:111–3.

    Article  PubMed  Google Scholar 

Download references

Funding

EFM is supported by the UTHealth/MD Anderson Cancer Center medical scientist training program T32GM129462. CWB is supported by grant R01DA044859.

Author information

Authors and Affiliations

  1. Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA

    Emily Frances Mendez & Consuelo Walss-Bass

Authors
  1. Emily Frances Mendez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Consuelo Walss-Bass
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EFM and CWB wrote, edited, and approved the article.

Corresponding author

Correspondence to Consuelo Walss-Bass.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mendez, E.F., Walss-Bass, C. Postmortem-derived iPSC models in substance use disorders research. Neuropsychopharmacol. 49, 349–350 (2024). https://doi.org/10.1038/s41386-023-01703-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41386-023-01703-3

  • Springer Nature Switzerland AG

Search

Navigation